Agent Capital related stories
All articles and analysis
Women-led venture capital firmsWe have updated our exclusive directory of more than 400 women-led venture capital firms from around the world.
Bioluminescence Ventures taps Murray as senior partnerMost recently, Murray was a general partner at Agent Capital.
- RNA medicines provider Orbital Therapeutics scores $270m Series A
ARCH Venture Partners led the round.
Illinois Municipal pension backs two diverse managersThe $55.1bn system committed to Agent Capital and Red Arts Capital as part of its diverse manager program.
VC-backed Entrada Therapeutics raises $181.5m for IPOEntrada Therapeutics, a biotech company, has raised $181.5 million for its IPO after pricing its over 9 million shares at $20 per share.
Immunitas Therapeutics procures $58m Series BImmunitas Therapeutics, a single cell genomics-based therapeutics company, has secured $58 million in Series B financing.
- Agent Capital collects $59.55m for sophomore fund
Agent Capital has raised $59.55 million for its second fund, according to an SEC filing.
- Agent Capital collects nearly $53m for sophomore fund
Agent Capital has raised nearly $53 million for its second fund, according to an SEC filing.
- Metagenomi grabs $65m Series A
Metagenomi, a next-generation gene editing company, has secured $65 million in Series A financing.
- VC-backed Pliant Therapeutics goes public
South San Francisco-based Pliant Therapeutics Inc, a developer of therapies that treat fibrosis, has raised $144 million for its IPO after it priced its 9 million shares at $16 per share.